Leukemia News, Articles | Today's Clinical Lab

More than 20,000 Americans are diagnosed with AML each year, making it one of the most common types of leukemia—and one of the most aggressive.

Researchers Find Breast Cancer Drug Boosts Leukemia Treatment

Oregon Health & Science University

OHSU researchers identified new drug combination that could overcome treatment resistance in acute myeloid leukemia

Among acute myeloid leukemia (AML) subtypes, acute promyelocytic leukemia (APL) is both clinically urgent and therapeutically promising.

Streamlining Acute Promyelocytic Leukemia Diagnosis: The Case for a Unified PML-RARA Testing Solution

Meghana Malur, PhD

Detecting all PML-RARA fusion isoforms in a single assay could help simplify the diagnostic workflow for acute promyelocytic leukemia

The research, published in Nature Genetics, focused specifically on the risk of blood cancers such as acute myeloid leukemia.

Genetic Study Suggests Ways to Catch Blood Cancer Earlier

Washington University School of Medicine

New understanding of how mutations interact could pave way for early detection, prevention strategies

OGT’s next-generation sequencing SureSeq™ Myeloid MRD Panel, which provides a flexible NGS workflow.

OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel

OGT

Ultralow variant detection enables a stronger characterization of a sample’s current AML status

Photo of blood sample collection tubes filled with blood samples from pregnant woman diagnosed with cancer during pregnancy

New Guidelines for Managing Blood Cancers in Pregnancy

Macquarie University

About 12.5 pregnancies per 100,000 are affected by blood cancers, and their incidence has been rising

Close-up photo of three half-empty blood bags hanging from a stand used for the blood transfusion process.

Testing for Residual Cancer before Blood Cell Transplant Is Crucial, Study Finds

Virginia Tech

New research highlights the feasibility of testing for lingering cancer cells for patients in remission from acute myeloid leukemia

Blood vacutainer labeled Acute myeloid leukemia against a disease report in the background.

New Computational Tool Characterizes Progenitor Cells in AML Patients

Center for Genomic Regulation

Findings may help reduce rates of relapse and improve the prognosis and successful treatment of acute myeloid lymphoma

Close-up of three vacutainers containing blood samples on a test requisition form beside a stethescope

Blood Test Identifies AML Patients at Risk of Posttransplant Relapse

National Institutes of Health

A small portion of acute myeloid leukemia patients in remission showed persisting mutations, which predicted their risk of death from cancer relapse

Pharmacotyping Provides a Blueprint for “True Precision Medicine”

St. Jude Children’s Research Hospital

Researchers have now comprehensively studied the pharmacogenomics of ALL revealing a wide variability

Mouse models show that blocking DUSP6 prevents chronic blood cancer from aggravating into lethal secondary acute myeloid leukemia (sAML).

Key Molecule Driving the Progression of Chronic Leukemia Identified

Swathi Kodaikal, MSc

Further research can alter the prognosis and improve quality of life in patients with leukemia

Leukemia